What is the underestimation of radiation dose to the pediatric thyroid gland from contrast enhanced CT, if contrast medium uptake is not taken into account?

The impact of iodine contrast agent on radiation dose of heart and blood: a comparison between coronary CT angiography and cardiac calcium scoring CT

BACKGROUND

Iodine contrast agent (CA) is widely used in cardiac computed tomography (CT). The CA can increase the organ radiation doses due to the photoelectric effect.

PURPOSE

To investigate the impact of CA on radiation dose in cardiac CT by comparing the radiation dose between contrast coronary CT angiography (CCTA) and non-contrast calcium scoring CT (CSCT).

MATERIAL AND METHODS

Radiation doses were computationally calculated for 30 individual patients who received CSCT and CCTA in the same exam session. The geometry and acquisition parameters were modeled in the simulations based on individual patient CT images and acquisitions. Doses in the presence and absence of CA were obtained in the aorta, left ventricle (LV), right ventricle (RV), and myocardial tissue (MT). The dose values were normalized by size-specific dose estimate (SSDE). The dose enhancement factors (DEFSSDE) were calculated as the ratio of doses in CCTA over doses in CSCT.

RESULTS

Compared to the CSCT scans, doses increase in the CCTA scans in the aorta (DEFSSDE = 2.14 ± 0.20), LV (DEFSSDE = 1.78 ± 0.26), and RV (DEFSSDE = 1.31 ± 0.22). A linear relation is observed between the local CA concentrations and the dose increase in the heart; DEFSSDE = 0.07*I(mg/mL) + 0.80 (R2 = 0.8; p < 0.01). The DEFSSDE in the MT (DEFSSDE = 0.96 ± 0.08) showed no noticeable impact of CA on the dose in this tissue. In addition, patient variability in the dose distributions was observed.

CONCLUSION

A linear causal relation exists between local CA concentration and increase in radiation dose in cardiac CT. For the same CT exposure, dose to the heart is on average 55% higher in contrast cardiac CT.

Optimization of the Parameters for the Test Bolus Technique in Computed Tomography Angiography of Head and Neck

OBJECTIVE

The aim of the study was to optimize low-dose scanning protocols for the test bolus technique in 64-detector computed tomography (CT) angiography (CTA) of the head and neck.

METHODS

A total of 250 patients were randomly divided into 5 groups of 50 patients each: conventional group (group A: 120 kV, 100 mA) and low-dose groups (group B: 100 kV, 100 mA; group C: 100 kV, 50 mA; group D: 80 kV, 100 mA; and group E: 80 kV, 50 mA). Subjective scores and objective measurements (CT values of the aortic arch, image noise, and signal-to-noise ratio) were used to evaluate the image quality and compare the radiation doses of the 5 groups.

RESULTS

The image quality of the 5 groups met the diagnostic requirements, with no significant difference in the subjective evaluation findings (P > 0.05). There were significant differences in the CT values between the conventional group and low-dose groups (P < 0.05); however, there was no significant difference between groups B and C and between groups D and E (P > 0.05). Moreover, the volume CT dose index and dose length product of groups B, C, D, and E decreased by 37.62%, 70.45%, 65.28%, and 83.39%, respectively, compared with those of group A. Although the image noise of the low-dose groups increased, an appropriate reduction in the tube voltage enhanced the contrast medium-induced x-ray attenuation and increased the CT value, which resulted in a nonsignificant difference in the signal-to-noise ratio. Therefore, the image quality of the low-dose groups was not affected compared with that of the conventional group.

CONCLUSIONS

In the test bolus technique in 64-detector CTA, the low-dose protocol of using 80 kV and 50 mA reduces the radiation dose by 83.39% compared with the conventional scan, without affecting the image quality.

The effect of contrast material on radiation dose during computed tomography pulmonary angiography

This study evaluated the impact of contrast material (CM) on radiation dose for adults undergoing computed tomography pulmonary angiography (CTPA). A previously developed physiologically based pharmacokinetic (PBPK) model and phantoms representing the average (reference) adult male and female individual were used to evaluate the iodine concentration in tissues as a function of time elapsed since the initiation of iodinated contrast medium administration. In order to estimate the radiation dose more accurately, a detailed model of pulmonary vessels was added to the phantoms. Then, the material composition of phantoms was modified to include the iodine concentration in different organs and tissues at different acquisition times after CM injection. The calculations were performed using Monte Carlo N-Particle extended code (MCNPX) version 2.6.0. The radiation dose estimates during CTPA were provided as a function of scan acquisition time after injection considering the distribution of iodinated CM within ICRP reference phantoms. It was shown that the estimated radiation dose to the lungs could be 31-40% (27-34%) larger when considering the effect of iodinated contrast administration with injection rate of 5 (3)mL/s. Moreover, the effective dose for contrast-enhanced CT (CECT) would be utmost 10-13% larger than that for non-enhanced CT (NECT). The radiation doses to the other organs in-/outside the scanned region would be decreased if the scan performed on time. In case of late scanning, absorbed dose decreases slightly for lungs (∼15-20%) whereas becomes (∼10% or more) higher than its NECT value for some organs such as heart muscle, kidneys, and spleen. To sum up, the late scanning (Δt>5s after the end of injection) is not recommended because of higher dose delivered to other organs than the lungs (particularly heart muscle).

Size-specific dose estimations for pediatric chest, abdomen/pelvis and head CT scans with the use of GATE

PURPOSE

The purpose of this study is to create an organ dose database for pediatric individuals undergoing chest, abdomen/pelvis, and head computed tomography (CT) examinations, and to report the differences in absorbed organ doses, when anatomical differences exist for pediatric patients.

METHODS

The GATE Monte Carlo (MC) toolkit was used to model the GE BrightSpeed Elite CT model. The simulated scanner model was validated with the standard Computed Tomography Dose Index (CTDI) head phantom. Twelve computational models (2.1-14 years old) were used. First, contributions to effective dose and absorbed doses per CTDI_vol and per 100 mAs were estimated for all organs. Then, doses per CTDI_vol were correlated with patient model weight for the organs inside the scan range for chest and abdomen/pelvis protocols. Finally, effective doses per dose-length product (DLP) were estimated and compared with the conventional conversion k-factors.

RESULTS

The system was validated against experimental CTDI_w measurements. The doses per CTDI_vol and per 100 mAs for selected organs were estimated. The magnitude of the dependency between the dose and the anatomical characteristics was calculated with the coefficient of determination at 0.5-0.7 for the internal scan organs for chest and abdomen/pelvis protocols. Finally, effective doses per DLP were compared with already published data, showing discrepancies between 13 and 29% and were correlated strongly with the total weight (R² > 0.8) for the chest and abdomen protocols.

CONCLUSIONS

Big differences in absorbed doses are reported even for patients of similar age or same gender, when anatomical differences exist on internal organs of the body.